Literature DB >> 11603877

Cancer education for clergy and lay church leaders.

G R Sadler1, J Sethee, L Tuzzio, M Sieben, C M Ko, H N Christ.   

Abstract

BACKGROUND: Reaching diverse population subgroups with information about cancer prevention/early detection, pain management, and clinical trials has historically been a significant public health challenge. A partnership between clergy and cancer educators might help reduce this challenge.
METHODS: Participating churches were randomized into two programs for delivering cancer education after their church leaders completed a baseline survey about their knowledge, attitudes, and roles related to the cancer ministry.
RESULTS: Clergy reported opportunities to use their acquired cancer knowledge, a high receptivity to their information, comfort discussing cancer care and clinical trials, and a strong recommendation that the educational program/partnership continue to be offered.

Entities:  

Mesh:

Year:  2001        PMID: 11603877     DOI: 10.1080/08858190109528757

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  4 in total

1.  Is religiosity related to attitudes toward clinical trials participation?

Authors:  Svetlana Daverio-Zanetti; Kathryn Schultz; Miguel A Martin del Campo; Vanessa Malcarne; Natasha Riley; Georgia Robins Sadler
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

2.  A cluster randomized controlled trial to increase breast cancer screening among African American women: the black cosmetologists promoting health program.

Authors:  Georgia Robins Sadler; Celine M Ko; Phillis Wu; Jennifer Alisangco; Sheila F Castañeda; Colleen Kelly
Journal:  J Natl Med Assoc       Date:  2011-08       Impact factor: 1.798

3.  Health promotion via deaf-friendly ministries.

Authors:  Georgia Robins Sadler; Patricia Branz; Matthew Fager; Sharon Seegers; Suzuho Shimasaki
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

Review 4.  The impact of socioeconomic status on access to cancer clinical trials.

Authors:  K Sharrocks; J Spicer; D R Camidge; S Papa
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.